Reserve group antibiotics — Parenteral > General injections > IV: 2 g in vial (as sodium) powder for injection; 4 g in vial (as sodium) powder for injection — Carbapenem resistant Acinetobacter baumannii — J01XX01 — — Added [EML section — Formulations — Indication — ATC codes — Combined with — Status]
Medicines
Cytotoxic medicines — Parenteral > General injections > unspecified: 100 mg in vial powder for injection
Parenteral > General injections > unspecified: 100 mg in vial powder for injection; 100 mg per mL in vial — Acute myeloid leukaemia with recurrent genetic abnormalities — L01BC01 — — Added [EML section — Formulations — Indication — ATC codes — Combined with — Status]
Access group antibiotics — Parenteral > General injections > unspecified: 1 g in vial (as sodium salt) powder for injection — Surgical site infection — J01DB04 — — Removed [EML section — Formulations — Indication — ATC codes — Combined with — Status]
Targeted therapies — Parenteral > General injections > IV: 60 mg in vial powder for injection; 150 mg in vial powder for injection; 440 mg in vial powder for injection — Carcinoma of breast, specialised type — L01FD01 — — Added [EML section — Formulations — Indication — ATC codes — Combined with — Status]
Cytotoxic medicines — Oral > Solid: 2 mg tablet — Unspecified malignant neoplasms of ill-defined or unspecified sites — L01AA02 — — Removed [EML section — Formulations — Indication — ATC codes — Combined with — Status]
Solutions correcting water, electrolyte and acid–base disturbances — Biscuit or paste of nutritional composition as determined by the UN joint statement on the community-based management of severe acute malnutrition and Codex alimentarius guidelines. — Acute malnutrition in infants, children or adolescents — — — Added [EML section — Formulations — Indication — ATC codes — Combined with — Status]
Reserve group antibiotics — Parenteral > General injections > IV: 1 g in vial + 1 g in vial powder for injection — Carbapenem resistant Acinetobacter baumannii — J01DH52 — — Added [EML section — Formulations — Indication — ATC codes — Combined with — Status]
Cytotoxic medicines — Oral > Solid: 50 mg tablet
Oral > Liquid: 20 mg per mL — Unspecified malignant neoplasms of ill-defined or unspecified sites — L01BB02 — — Removed [EML section — Formulations — Indication — ATC codes — Combined with — Status]
Antiarrhythmic medicines — Parenteral > General injections > IV: 250 µg per mL in 2 mL ampoule
Oral > Liquid: 50 µg per mL
Oral > Solid: 62.5 µg; 250 µg — Cardiac arrhythmia — C01AA05 — — Added [EML section — Formulations — Indication — ATC codes — Combined with — Status]
Lipid-lowering agents — — Mixed hyperlipidaemia — — — Added [EML section — Formulations — Indication — ATC codes — Combined with — Status]
Medicines for anxiety disorders — — Panic disorder — — — Added [EML section — Formulations — Indication — ATC codes — Combined with — Status]
Medicines for other common symptoms in palliative care — Oral > Solid: 2 mg solid oral dosage form — Palliative care — A07DA03 — — Added [EML section — Formulations — Indication — ATC codes — Combined with — Status]
Antimalarial medicines > For curative treatment — Parenteral > General injections > IV: 40 mg per mL in 5 mL ampoule (as hydrochloride, phosphate or sulfate)
Oral > Liquid: 50 mg per 5 mL syrup (as phosphate or sulfate)
Oral > Solid: 150 mg tablet (as phosphate or sulfate); 100 mg tablet (as phosphate or sulfate) — Malaria due to Plasmodium falciparum — P01BA01 — — Removed [EML section — Formulations — Indication — ATC codes — Combined with — Status]
Dermatological medicines > Medicines affecting skin differentiation and proliferation — Local > Topical > Cream: 50 µg per mL (0.005%)
Local > Topical > Lotion: 50 µg per mL (0.005%)
Local > Topical > Ointment: 50 µg per mL (0.005%) — Psoriasis of unspecified type — D05AX02 — — Added [EML section — Formulations — Indication — ATC codes — Combined with — Status]
Lipid-lowering agents — Oral > Solid: 5 mg; 10 mg; 20 mg; 40 mg — Coronary atherosclerosis — C10AA01 — — Added [EML section — Formulations — Indication — ATC codes — Combined with — Status]
